A detailed history of Walthausen & Co., LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Walthausen & Co., LLC holds 19,226 shares of HAE stock, worth $1.7 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
19,226
Previous 30,566 37.1%
Holding current value
$1.7 Million
Previous $1.99 Million 28.56%
% of portfolio
1.19%
Previous 0.89%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $717,822 - $892,004
11,340 Added 58.98%
30,566 $1.99 Million
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $717,822 - $892,004
-11,340 Reduced 37.1%
19,226 $1.42 Million
Q2 2022

Aug 12, 2022

SELL
$49.27 - $66.08 $219,744 - $294,716
-4,460 Reduced 12.73%
30,566 $1.99 Million
Q1 2022

May 11, 2022

BUY
$43.77 - $63.22 $1.53 Million - $2.21 Million
35,026 New
35,026 $2.21 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.52B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Walthausen & Co., LLC Portfolio

Follow Walthausen & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walthausen & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walthausen & Co., LLC with notifications on news.